CONTRACT NOTICE – NATIONAL
|
| SUPPLIES |
1 Authority Details
|
1.1
|
Authority Name and Address
|
|
Swansea University |
Procurement Office, Swansea University, Singleton Park, |
Swansea |
SA2 8PP |
UK |
Sue Davies |
+44 1792295890 |
|
|
www.swansea.ac.uk
https://etenderwales.bravosolution.co.uk/home.html
https://etenderwales.bravosolution.co.uk/home.html |
|
1.2
|
Address from which documentation may be obtained
As in 1.1
|
1.3
|
Completed documents must be returned to:
As in 1.1
|
2 Contract Details
|
2.1
|
Title
Tender for a Live-Cell Analysis System
|
2.2
|
Description of the goods or services required
The Reproductive Biology and Gynaecological Oncology (RBGO) group within the Faculty of Medicine, Health & Life Science at Swansea University wish to procure a Live Cell Analysis system to expand the capabilities of the group. Procurement of this instrument will support academic and industrial collaborations developed as part of two ERDF funded, SMARTExpertise projects; the Cluster for Epigenetic and ADC Therapeutics (CEAT) and ReNeuron, IgInnovations and Swansea University's development of Exosomes towards clinical utility (RISE).
A condition of the funding body covering this equipment is that it must be invoiced (not necessarily delivered) on receipt of a Swansea University Purchase Order, prior to 31st March 2023, so only suppliers able and willing to issue an invoice by this date should tender.
The RBGO Group wish to conduct an open tender process in order to source a suitable supplier of a live cell analysis system. The system should allow the group to monitor live 2D and 3D cell cultures in an optimal environment for growth. The system should allow the user to obtain data such as confluency, spheroid growth rate, cell migration, apoptosis, cell cycle stage and cytotoxicity.
NOTE: The authority is using eTenderwales to carry out this procurement process. To obtain further information record your interest on Sell2Wales at https://www.sell2wales.gov.wales/search/search_switch.aspx?ID=127596
|
2.3
|
Notice Coding and Classification
|
|
|
|
|
33000000 |
|
Medical equipments, pharmaceuticals and personal care products |
|
33100000 |
|
Medical equipments |
|
33110000 |
|
Imaging equipment for medical, dental and veterinary use |
|
33190000 |
|
Miscellaneous medical devices and products |
|
33197000 |
|
Medical computer equipment |
|
33698100 |
|
Microbiological cultures |
|
38430000 |
|
Detection and analysis apparatus |
|
38432000 |
|
Analysis apparatus |
|
38434540 |
|
Biomedical equipment |
|
|
|
|
|
1018 |
|
Swansea |
|
2.4
|
Total quantity or scope of tender
As detailed within the suite of tender documents found on itt 100080 on etenderwales BravoSolution
|
3 Conditions for Participation
|
3.1
|
Minimum standards and qualification required
This tender is being conducted electronically via etenderwales BravoSolution, therefore only submissions uploaded to that website by the tender deadline given, can be considered
|
4 Administrative Information
|
4.1
|
Type of Procedure
Single stage
|
4.2
|
Reference number attributed to the notice by the contracting authority
SU108(23)
|
4.3
|
Time LimitsTime-limit for receipt of completed tenders
20-01-2023
Time 12:00
Estimated award date
10-02-2023 |
4.5
|
Language or languages in which tenders or requests to participate can be drawn upEN
CY
|
4.6
|
Tender Submission Postbox
|
5 Other Information
|
5.1
|
Additional Information
(WA Ref:127596)
Relates to the following project/programme financed by EU Community Funds: Procurement of this instrument will support academic and industrial collaborations developed as part of two ERDF funded, SMARTExpertise projects; the Cluster for Epigenetic and ADC Therapeutics (CEAT) and ReNeuron, IgInnovations and Swansea University's development of Exosomes towards clinical utility (RISE).
The buyer considers that this contract is suitable for consortia bidding.
|
5.2
|
Additional Documentation
|
5.3
|
Publication date of this notice 20-12-2022 |